Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Deferred Tax Liability (2022 - 2023)

Bicycle Therapeutics (BCYC) has disclosed Non-Current Deferred Tax Liability for 2 consecutive years, with $3.4 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Non-Current Deferred Tax Liability fell 23.1% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Dec 2023, down 23.1%, and an annual FY2023 reading of $3.4 million, down 23.1% over the prior year.
  • Non-Current Deferred Tax Liability was $3.4 million for Q4 2023 at Bicycle Therapeutics, down from $4.4 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $4.4 million in Q4 2022 and bottomed at $3.4 million in Q4 2023.